Common effects include nausea, diarrhoea, vomiting, abdominal pain, constipation and decreased appetite, especially during dose increases
1 In July 2023, the FDA began investigating a potential risk of suicidal ideation behavior associated with GLP-1 medications after receiving postmarketing reports from patients using these drugs
Cost-effectiveness of early intervention models Economic analyses reveal phentermine-topiramate as potentially cost-effective at USD 56,876 per QALY gained versus lifestyle counseling
(2017) IGFBP-2 and IGF-1 LR3 in GLUT-4 Translocation in 3T3-L1 Adipocytes Oxid Med Cell Longev
The original ILS photographs also show substantial orange-red staining across the test areas, alongside what appears to be a single visible line
The gastrointestinal tract and liver degrade a significant portion of ingested GSH before it enters systemic circulation